Targeting Burkitt lymphoma with a tumor cell–specific heptamethine carbocyanine‐cisplatin conjugate

BACKGROUND: Burkitt lymphoma is a fast‐growing mature B cell malignancy, whose genetic hallmark is translocation and activation of the c‐myc gene. Prompt multiagent immunochemotherapy regimens can have favorable outcomes, but prognosis is poor in refractory or relapsed disease. We previously identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrdenovic, Stefan, Zhang, Yi, Wang, Ruoxiang, Yin, Lijuan, Chu, Gina Chia‐Yi, Yin, Liyuan, Lewis, Michael, Heffer, Marija, Zhau, Haiyen E., Chung, Leland W. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618854/
https://www.ncbi.nlm.nih.gov/pubmed/30840322
http://dx.doi.org/10.1002/cncr.32033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618854/
https://www.ncbi.nlm.nih.gov/pubmed/30840322
http://dx.doi.org/10.1002/cncr.32033

Ejemplares similares